Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions
Since commencement of COVID-19 pandemic, several SARS-CoV-2 variants have emerged amid containment efforts via vaccination. The Delta variant (B.1.617.2), discovered in October 2020, was designated as a VOC by the WHO on May 11, 2021. The enhanced transmissibility of Delta variant has been associate...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis Group
2022-11-01
|
| Collection: | Human Vaccines & Immunotherapeutics |
| Sujets: | |
| Accès en ligne: | http://dx.doi.org/10.1080/21645515.2022.2068883 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|